Individual research recommendation details

Recommendation ID

NG162/1

Question

Risk of radiotherapy in people with cancer and COVID-19: Are patients with cancer and COVID-19 who are receiving/have recently received radiotherapy (that is, within the 4 weeks preceding a diagnosis of COVID-19) at increased risk of severe COVID-19 illness or death?

Any explanatory notes
(if applicable)

It is recommended that this research should also consider:

• if there are specific types of radiotherapy carrying increased risk of poor outcomes from COVID-19
• if there are specific types of cancer for which radiotherapy may carry increased risk of poor outcomes from COVID-19
• if there is a difference in any risk of poor outcomes from COVID-19 between people who have received SACT alone, radiotherapy alone, or both SACT and radiotherapy
• if there is a difference in any risk of poor outcomes from COVID-19 between children and young people who have received radiotherapy and adults who have received radiotherapy

Source guidance details

Comes from guidance

COVID-19 rapid guideline: delivery of radiotherapy

Number

NG162

Date issued

March 2020

Other details